<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-03-05" modified="2020-10-07" version="201">
<accession>O75925</accession>
<accession>B2RB67</accession>
<accession>B3KSY9</accession>
<accession>C5J4B4</accession>
<accession>Q147X4</accession>
<accession>Q99751</accession>
<accession>Q9UN02</accession>
<name>PIAS1_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 SUMO-protein ligase PIAS1</fullName>
<ecNumber>2.3.2.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DEAD/H box-binding protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="39">E3 SUMO-protein transferase PIAS1</fullName>
</alternativeName>
<alternativeName>
<fullName>Gu-binding protein</fullName>
<shortName>GBP</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein inhibitor of activated STAT protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>RNA helicase II-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIAS1</name>
<name type="synonym">DDXBP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="10626" last="10631">
<title>Inhibition of Stat1-mediated gene activation by PIAS1.</title>
<authorList>
<person name="Liu B."/>
<person name="Liao J."/>
<person name="Rao X."/>
<person name="Kushner S.A."/>
<person name="Chung C.D."/>
<person name="Chang D.D."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="9724754"/>
<dbReference type="DOI" id="10.1073/pnas.95.18.10626"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH STAT1</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mol. Endocrinol." volume="14" first="14" last="26">
<title>Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.</title>
<authorList>
<person name="Tan J."/>
<person name="Hall S.H."/>
<person name="Hamil K.G."/>
<person name="Grossman G."/>
<person name="Petrusz P."/>
<person name="Liao J."/>
<person name="Shuai K."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="10628744"/>
<dbReference type="DOI" id="10.1210/mend.14.1.0408"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2009" name="BMC Genomics" volume="10" first="518" last="518">
<title>Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site.</title>
<authorList>
<person name="Wang P."/>
<person name="Yu P."/>
<person name="Gao P."/>
<person name="Shi T."/>
<person name="Ma D."/>
</authorList>
<dbReference type="PubMed" id="19906316"/>
<dbReference type="DOI" id="10.1186/1471-2164-10-518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Amygdala</tissue>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Biochem. Biophys. Res. Commun." volume="234" first="335" last="340">
<title>Cloning and characterization of Gu/RH-II binding protein.</title>
<authorList>
<person name="Valdez B.C."/>
<person name="Henning D."/>
<person name="Perlaky L."/>
<person name="Busch R.K."/>
<person name="Busch H."/>
</authorList>
<dbReference type="PubMed" id="9177271"/>
<dbReference type="DOI" id="10.1006/bbrc.1997.6642"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 7-651 (ISOFORM 1)</scope>
<scope>INTERACTION WITH DDX21</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Biochem. J." volume="359" first="485" last="496">
<title>LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1.</title>
<authorList>
<person name="Weiskirchen R."/>
<person name="Moser M."/>
<person name="Weiskirchen S."/>
<person name="Erdel M."/>
<person name="Dahmen S."/>
<person name="Buettner R."/>
<person name="Gressner A.M."/>
</authorList>
<dbReference type="PubMed" id="11672422"/>
<dbReference type="DOI" id="10.1042/0264-6021:3590485"/>
</citation>
<scope>INTERACTION WITH CSRP2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Mol. Cell" volume="8" first="713" last="718">
<title>Involvement of PIAS1 in the sumoylation of tumor suppressor p53.</title>
<authorList>
<person name="Kahyo T."/>
<person name="Nishida T."/>
<person name="Yasuda H."/>
</authorList>
<dbReference type="PubMed" id="11583632"/>
<dbReference type="DOI" id="10.1016/s1097-2765(01)00349-5"/>
</citation>
<scope>INTERACTION WITH UBE2I; SUMO1 AND TP53</scope>
<scope>MUTAGENESIS OF CYS-351</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="3880" last="3887">
<title>Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.</title>
<authorList>
<person name="Gross M."/>
<person name="Liu B."/>
<person name="Tan J.-A."/>
<person name="French F.S."/>
<person name="Carey M."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="11439351"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204489"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="42981" last="42986">
<title>SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling.</title>
<authorList>
<person name="Rui H.L."/>
<person name="Fan E."/>
<person name="Zhou H.M."/>
<person name="Xu Z."/>
<person name="Zhang Y."/>
<person name="Lin S.C."/>
</authorList>
<dbReference type="PubMed" id="12223491"/>
<dbReference type="DOI" id="10.1074/jbc.m208099200"/>
</citation>
<scope>INTERACTION WITH AXIN1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="50131" last="50136">
<title>Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes.</title>
<authorList>
<person name="Miyauchi Y."/>
<person name="Yogosawa S."/>
<person name="Honda R."/>
<person name="Nishida T."/>
<person name="Yasuda H."/>
</authorList>
<dbReference type="PubMed" id="12393906"/>
<dbReference type="DOI" id="10.1074/jbc.m208319200"/>
</citation>
<scope>SUMOYLATION OF MDM2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="5206" last="5215">
<title>Transcription factor Sp3 is silenced through SUMO modification by PIAS1.</title>
<authorList>
<person name="Sapetschnig A."/>
<person name="Rischitor G."/>
<person name="Braun H."/>
<person name="Doll A."/>
<person name="Schergaut M."/>
<person name="Melchior F."/>
<person name="Suske G."/>
</authorList>
<dbReference type="PubMed" id="12356736"/>
<dbReference type="DOI" id="10.1093/emboj/cdf510"/>
</citation>
<scope>INTERACTION WITH SP3 AND UBE2I</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="2872" last="2877">
<title>Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.</title>
<authorList>
<person name="Schmidt D."/>
<person name="Mueller S."/>
</authorList>
<dbReference type="PubMed" id="11867732"/>
<dbReference type="DOI" id="10.1073/pnas.052559499"/>
</citation>
<scope>INTERACTION WITH JUN AND TP53</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Genes Dev." volume="17" first="3048" last="3061">
<title>SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.</title>
<authorList>
<person name="Dobreva G."/>
<person name="Dambacher J."/>
<person name="Grosschedl R."/>
</authorList>
<dbReference type="PubMed" id="14701874"/>
<dbReference type="DOI" id="10.1101/gad.1153003"/>
</citation>
<scope>INTERACTION WITH SATB2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="47434" last="47440">
<title>PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.</title>
<authorList>
<person name="Kadare G."/>
<person name="Toutant M."/>
<person name="Formstecher E."/>
<person name="Corvol J.C."/>
<person name="Carnaud M."/>
<person name="Boutterin M.C."/>
<person name="Girault J.A."/>
</authorList>
<dbReference type="PubMed" id="14500712"/>
<dbReference type="DOI" id="10.1074/jbc.m308562200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PTK2/FAK1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="36121" last="36131">
<title>Repression of the transactivating capacity of the oncoprotein PLAG1 by SUMOylation.</title>
<authorList>
<person name="Van Dyck F."/>
<person name="Delvaux E.L.D."/>
<person name="Van de Ven W.J.M."/>
<person name="Chavez M.V."/>
</authorList>
<dbReference type="PubMed" id="15208321"/>
<dbReference type="DOI" id="10.1074/jbc.m401753200"/>
</citation>
<scope>INTERACTION WITH PLAG1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="16664" last="16671">
<title>Sumoylation delimits KLF8 transcriptional activity associated with the cell cycle regulation.</title>
<authorList>
<person name="Wei H."/>
<person name="Wang X."/>
<person name="Gan B."/>
<person name="Urvalek A.M."/>
<person name="Melkoumian Z.K."/>
<person name="Guan J.-L."/>
<person name="Zhao J."/>
</authorList>
<dbReference type="PubMed" id="16617055"/>
<dbReference type="DOI" id="10.1074/jbc.m513135200"/>
</citation>
<scope>INTERACTION WITH KLF8</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Cell" volume="129" first="903" last="914">
<title>Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.</title>
<authorList>
<person name="Liu B."/>
<person name="Yang Y."/>
<person name="Chernishof V."/>
<person name="Loo R.R."/>
<person name="Jang H."/>
<person name="Tahk S."/>
<person name="Yang R."/>
<person name="Mink S."/>
<person name="Shultz D."/>
<person name="Bellone C.J."/>
<person name="Loo J.A."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="17540171"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.03.056"/>
</citation>
<scope>INTERACTION WITH CHUK</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="5866" last="5876">
<title>SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.</title>
<authorList>
<person name="Jacobs A.M."/>
<person name="Nicol S.M."/>
<person name="Hislop R.G."/>
<person name="Jaffray E.G."/>
<person name="Hay R.T."/>
<person name="Fuller-Pace F.V."/>
</authorList>
<dbReference type="PubMed" id="17369852"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210387"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-522</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="118" last="132">
<title>PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.</title>
<authorList>
<person name="Weber S."/>
<person name="Maass F."/>
<person name="Schuemann M."/>
<person name="Krause E."/>
<person name="Suske G."/>
<person name="Bauer U.M."/>
</authorList>
<dbReference type="PubMed" id="19136629"/>
<dbReference type="DOI" id="10.1101/gad.489409"/>
</citation>
<scope>RETRACTED PAPER</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Genes Dev." volume="25" first="1451" last="1451">
<title>Retraction. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.</title>
<authorList>
<person name="Weber S."/>
<person name="Maass F."/>
<person name="Schuemann M."/>
<person name="Krause E."/>
<person name="Suske G."/>
<person name="Bauer U.M."/>
</authorList>
<dbReference type="PubMed" id="21724836"/>
</citation>
<scope>RETRACTION NOTICE OF PUBMED:19136629</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-510</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="43793" last="43808">
<title>SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function.</title>
<authorList>
<person name="Cong L."/>
<person name="Pakala S.B."/>
<person name="Ohshiro K."/>
<person name="Li D.Q."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="21965678"/>
<dbReference type="DOI" id="10.1074/jbc.m111.267237"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MTA1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-485; SER-488 AND SER-503</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-467; SER-468 AND SER-503</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46 AND LYS-238</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46; LYS-137 AND LYS-238</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46 AND LYS-137</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="26509" last="26509">
<title>SUMO5, a novel poly-sumo isoform, regulates pml nuclear bodies.</title>
<authorList>
<person name="Liang Y.C."/>
<person name="Lee C.C."/>
<person name="Yao Y.L."/>
<person name="Lai C.C."/>
<person name="Schmitz M.L."/>
<person name="Yang W.M."/>
</authorList>
<dbReference type="PubMed" id="27211601"/>
<dbReference type="DOI" id="10.1038/srep26509"/>
</citation>
<scope>INTERACTION WITH SUMO1P1/SUMO5</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="363" last="363">
<title>HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.</title>
<authorList>
<person name="Wang W.F."/>
<person name="Yan L."/>
<person name="Liu Z."/>
<person name="Liu L.X."/>
<person name="Lin J."/>
<person name="Liu Z.Y."/>
<person name="Chen X.P."/>
<person name="Zhang W."/>
<person name="Xu Z.Z."/>
<person name="Shi T."/>
<person name="Li J.M."/>
<person name="Zhao Y.L."/>
<person name="Meng G."/>
<person name="Xia Y."/>
<person name="Li J.Y."/>
<person name="Zhu J."/>
</authorList>
<dbReference type="PubMed" id="28842558"/>
<dbReference type="DOI" id="10.1038/s41467-017-00476-w"/>
</citation>
<scope>INTERACTION WITH PRDM1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-40; LYS-46; LYS-137; LYS-238; LYS-453 AND LYS-493</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31455" last="31461">
<title>NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomers.</title>
<authorList>
<person name="Okubo S."/>
<person name="Hara F."/>
<person name="Tsuchida Y."/>
<person name="Shimotakahara S."/>
<person name="Suzuki S."/>
<person name="Hatanaka H."/>
<person name="Yokoyama S."/>
<person name="Tanaka H."/>
<person name="Yasuda H."/>
<person name="Shindo H."/>
</authorList>
<dbReference type="PubMed" id="15133049"/>
<dbReference type="DOI" id="10.1074/jbc.m403561200"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-65</scope>
<scope>INTERACTION WITH TP53 AND DNA-BINDING</scope>
</reference>
<comment type="function">
<text evidence="13 25 32">Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. In vitro, binds A/T-rich DNA. The effects of this transcriptional coregulation, transactivation or silencing, may vary depending upon the biological context. Sumoylates PML (at'Lys-65' and 'Lys-160') and PML-RAR and promotes their ubiquitin-mediated degradation. PIAS1-mediated sumoylation of PML promotes its interaction with CSNK2A1/CK2 which in turn promotes PML phosphorylation and degradation (By similarity). Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation. Plays a dynamic role in adipogenesis by promoting the SUMOylation and degradation of CEBPB (By similarity).</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein sumoylation.</text>
</comment>
<comment type="subunit">
<text evidence="12 19 20 21 22 23 25 26 27 28 29 30 31 32 33 34 35 36">Interacts with NCOA2 and AR. Interacts with NR2C1; the interaction promotes its sumoylation (By similarity). Interacts with DDX21, CSRP2, AXIN1, JUN, UBE2I, SUMO1, SATB2, PLAG1, TP53 and STAT1 (dimer), following IFNA1-stimulation. Interacts with SP3 (preferentially when SUMO-modified). Interacts with KLF8; the interaction results in SUMO ligation and repression of KLF8 transcriptional activity and of its cell cycle progression into G(1) phase. Interacts with CHUK/IKKA; this interaction induces PIAS1 phosphorylation. Interacts with PTK2/FAK1; the interaction promotes its sumoylation. Interacts with DDX5. Interacts with PML (By similarity). Interacts with MTA1. Interacts with SUMO1P1/SUMO5 (PubMed:27211601). Interacts with PRDM1/Blimp-1 (PubMed:28842558).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-629434">
<id>O75925</id>
</interactant>
<interactant intactId="EBI-2339650">
<id>Q9UKL3</id>
<label>CASP8AP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-629434">
<id>O75925</id>
</interactant>
<interactant intactId="EBI-867196">
<id>Q9UIS9</id>
<label>MBD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-629434">
<id>O75925</id>
</interactant>
<interactant intactId="EBI-948789">
<id>O75626</id>
<label>PRDM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-629434">
<id>O75925</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-629434">
<id>O75925</id>
</interactant>
<interactant intactId="EBI-8826488">
<id>PRO_0000037946</id>
<dbReference type="UniProtKB" id="P29991"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24 35">Nucleus speckle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="12">Nucleus</location>
<location evidence="12">PML body</location>
</subcellularLocation>
<text>Interaction with CSRP2 may induce a partial redistribution along the cytoskeleton.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O75925-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O75925-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056219"/>
</isoform>
<isoform>
<id>O75925-3</id>
<name>3</name>
<sequence type="described" ref="VSP_057195 VSP_057196"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="18 35">Expressed in numerous tissues with highest level in testis.</text>
</comment>
<comment type="domain">
<text>The LXXLL motif is a transcriptional coregulator signature.</text>
</comment>
<comment type="domain">
<text evidence="12">The SP-RING-type domain is required for promoting EKLF sumoylation.</text>
</comment>
<comment type="PTM">
<text evidence="21 24">Sumoylated.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the PIAS family.</text>
</comment>
<comment type="caution">
<text evidence="40 41">A paper showing that PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling has been retracted, because some of the data was found to be deliberately falsified.</text>
</comment>
<dbReference type="EC" id="2.3.2.-"/>
<dbReference type="EMBL" id="AF077951">
<property type="protein sequence ID" value="AAC36702.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167160">
<property type="protein sequence ID" value="AAD49722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ997900">
<property type="protein sequence ID" value="ACR77525.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK094641">
<property type="protein sequence ID" value="BAG52901.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314515">
<property type="protein sequence ID" value="BAG37114.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC107871">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC135628">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC118587">
<property type="protein sequence ID" value="AAI18588.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC121797">
<property type="protein sequence ID" value="AAI21798.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U78524">
<property type="protein sequence ID" value="AAB58488.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45290.1">
<molecule id="O75925-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81902.1">
<molecule id="O75925-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307616.1">
<molecule id="O75925-2"/>
<property type="nucleotide sequence ID" value="NM_001320687.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057250.1">
<molecule id="O75925-1"/>
<property type="nucleotide sequence ID" value="NM_016166.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016878177.1">
<molecule id="O75925-2"/>
<property type="nucleotide sequence ID" value="XM_017022688.1"/>
</dbReference>
<dbReference type="PDB" id="1V66">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-65"/>
</dbReference>
<dbReference type="PDBsum" id="1V66"/>
<dbReference type="BMRB" id="O75925"/>
<dbReference type="SMR" id="O75925"/>
<dbReference type="BioGRID" id="114124">
<property type="interactions" value="127"/>
</dbReference>
<dbReference type="CORUM" id="O75925"/>
<dbReference type="DIP" id="DIP-5970N"/>
<dbReference type="ELM" id="O75925"/>
<dbReference type="IntAct" id="O75925">
<property type="interactions" value="59"/>
</dbReference>
<dbReference type="MINT" id="O75925"/>
<dbReference type="STRING" id="9606.ENSP00000249636"/>
<dbReference type="iPTMnet" id="O75925"/>
<dbReference type="PhosphoSitePlus" id="O75925"/>
<dbReference type="BioMuta" id="PIAS1"/>
<dbReference type="EPD" id="O75925"/>
<dbReference type="jPOST" id="O75925"/>
<dbReference type="MassIVE" id="O75925"/>
<dbReference type="MaxQB" id="O75925"/>
<dbReference type="PaxDb" id="O75925"/>
<dbReference type="PeptideAtlas" id="O75925"/>
<dbReference type="PRIDE" id="O75925"/>
<dbReference type="ProteomicsDB" id="3657"/>
<dbReference type="ProteomicsDB" id="50293">
<molecule id="O75925-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="26284">
<property type="antibodies" value="350 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000249636">
<molecule id="O75925-1"/>
<property type="protein sequence ID" value="ENSP00000249636"/>
<property type="gene ID" value="ENSG00000033800"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000545237">
<molecule id="O75925-2"/>
<property type="protein sequence ID" value="ENSP00000438574"/>
<property type="gene ID" value="ENSG00000033800"/>
</dbReference>
<dbReference type="GeneID" id="8554"/>
<dbReference type="KEGG" id="hsa:8554"/>
<dbReference type="UCSC" id="uc002aqz.4">
<molecule id="O75925-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8554"/>
<dbReference type="DisGeNET" id="8554"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000033800.13"/>
<dbReference type="GeneCards" id="PIAS1"/>
<dbReference type="HGNC" id="HGNC:2752">
<property type="gene designation" value="PIAS1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000033800">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="603566">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O75925"/>
<dbReference type="OpenTargets" id="ENSG00000033800"/>
<dbReference type="PharmGKB" id="PA33285"/>
<dbReference type="eggNOG" id="KOG2169">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203531"/>
<dbReference type="HOGENOM" id="CLU_020768_3_0_1"/>
<dbReference type="InParanoid" id="O75925"/>
<dbReference type="KO" id="K04706"/>
<dbReference type="OMA" id="RENHGHP"/>
<dbReference type="OrthoDB" id="1205949at2759"/>
<dbReference type="PhylomeDB" id="O75925"/>
<dbReference type="TreeFam" id="TF323787"/>
<dbReference type="PathwayCommons" id="O75925"/>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3232142">
<property type="pathway name" value="SUMOylation of ubiquitinylation proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3899300">
<property type="pathway name" value="SUMOylation of transcription cofactors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4551638">
<property type="pathway name" value="SUMOylation of chromatin organization proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5696395">
<property type="pathway name" value="Formation of Incision Complex in GG-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877312">
<property type="pathway name" value="Regulation of IFNG signaling"/>
</dbReference>
<dbReference type="SignaLink" id="O75925"/>
<dbReference type="SIGNOR" id="O75925"/>
<dbReference type="UniPathway" id="UPA00886"/>
<dbReference type="BioGRID-ORCS" id="8554">
<property type="hits" value="65 hits in 887 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PIAS1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O75925"/>
<dbReference type="GeneWiki" id="PIAS1"/>
<dbReference type="GenomeRNAi" id="8554"/>
<dbReference type="Pharos" id="O75925">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O75925"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="RNAct" id="O75925">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000033800">
<property type="expression patterns" value="Expressed in bone marrow and 245 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O75925">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O75925">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0061665">
<property type="term" value="F:SUMO ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019789">
<property type="term" value="F:SUMO transferase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription coregulator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033235">
<property type="term" value="P:positive regulation of protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051152">
<property type="term" value="P:positive regulation of smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0065004">
<property type="term" value="P:protein-DNA complex assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060334">
<property type="term" value="P:regulation of interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.720.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.120.780">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR023321">
<property type="entry name" value="PINIT"/>
</dbReference>
<dbReference type="InterPro" id="IPR038654">
<property type="entry name" value="PINIT_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003034">
<property type="entry name" value="SAP_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036361">
<property type="entry name" value="SAP_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004181">
<property type="entry name" value="Znf_MIZ"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="Pfam" id="PF14324">
<property type="entry name" value="PINIT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02891">
<property type="entry name" value="zf-MIZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00513">
<property type="entry name" value="SAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF68906">
<property type="entry name" value="SSF68906"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51466">
<property type="entry name" value="PINIT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50800">
<property type="entry name" value="SAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51044">
<property type="entry name" value="ZF_SP_RING"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="E3 SUMO-protein ligase PIAS1" id="PRO_0000218974">
<location>
<begin position="2"/>
<end position="651"/>
</location>
</feature>
<feature type="domain" description="SAP" evidence="15">
<location>
<begin position="11"/>
<end position="45"/>
</location>
</feature>
<feature type="domain" description="PINIT" evidence="17">
<location>
<begin position="124"/>
<end position="288"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="520"/>
<end position="523"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="557"/>
<end position="560"/>
</location>
</feature>
<feature type="repeat" description="3; approximate">
<location>
<begin position="598"/>
<end position="601"/>
</location>
</feature>
<feature type="repeat" description="4; approximate">
<location>
<begin position="612"/>
<end position="615"/>
</location>
</feature>
<feature type="zinc finger region" description="SP-RING-type" evidence="16">
<location>
<begin position="320"/>
<end position="397"/>
</location>
</feature>
<feature type="region of interest" description="SUMO1-binding" evidence="12">
<location>
<begin position="462"/>
<end position="473"/>
</location>
</feature>
<feature type="region of interest" description="4 X 4 AA repeats of N-T-S-L">
<location>
<begin position="520"/>
<end position="615"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif">
<location>
<begin position="19"/>
<end position="23"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="14">
<location>
<begin position="56"/>
<end position="64"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="14">
<location>
<begin position="368"/>
<end position="380"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="577"/>
<end position="634"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="5">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="467"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="468"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="483"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="485"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="487"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="488"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 6 7">
<location>
<position position="503"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="510"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="522"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="40"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8 9 10 11">
<location>
<position position="46"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 10 11">
<location>
<position position="137"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8 10 11">
<location>
<position position="238"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="453"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="493"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056219" evidence="37">
<original>MADSAEL</original>
<variation>MFTLQDSYV</variation>
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057195" evidence="38">
<original>IKEKLTADPDSEIA</original>
<variation>STYDKLISLIQLFC</variation>
<location>
<begin position="312"/>
<end position="325"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057196" evidence="38">
<location>
<begin position="326"/>
<end position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of UBE2I-binding; almost complete loss of promotion of TP53 sumoylation; no loss of SUMO1- and TP53-binding." evidence="19">
<original>C</original>
<variation>A</variation>
<variation>S</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC36702." ref="1" evidence="39">
<original>E</original>
<variation>K</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC36702." ref="1" evidence="39">
<original>IVV</original>
<variation>MC</variation>
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB58488." ref="6" evidence="39">
<original>S</original>
<variation>T</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="6"/>
<end position="11"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="16"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="34"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="51"/>
<end position="63"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1V66"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88907"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255"/>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00186"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00452"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00799"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11439351"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11583632"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11672422"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11867732"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12223491"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12356736"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12393906"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14500712"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14701874"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15133049"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15208321"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16617055"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17369852"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17540171"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21965678"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27211601"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28842558"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9177271"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9724754"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19906316"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19136629"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21724836"/>
</source>
</evidence>
<sequence length="651" mass="71836" checksum="AA69338221124119" modified="2002-03-05" version="2">MADSAELKQMVMSLRVSELQVLLGYAGRNKHGRKHELLTKALHLLKAGCSPAVQMKIKELYRRRFPQKIMTPADLSIPNVHSSPMPATLSPSTIPQLTYDGHPASSPLLPVSLLGPKHELELPHLTSALHPVHPDIKLQKLPFYDLLDELIKPTSLASDNSQRFRETCFAFALTPQQVQQISSSMDISGTKCDFTVQVQLRFCLSETSCPQEDHFPPNLCVKVNTKPCSLPGYLPPTKNGVEPKRPSRPINITSLVRLSTTVPNTIVVSWTAEIGRNYSMAVYLVKQLSSTVLLQRLRAKGIRNPDHSRALIKEKLTADPDSEIATTSLRVSLLCPLGKMRLTIPCRALTCSHLQCFDATLYIQMNEKKPTWVCPVCDKKAPYEHLIIDGLFMEILKYCTDCDEIQFKEDGTWAPMRSKKEVQEVSASYNGVDGCLSSTLEHQVASHHQSSNKNKKVEVIDLTIDSSSDEEEEEPSAKRTCPSLSPTSPLNNKGILSLPHQASPVSRTPSLPAVDTSYINTSLIQDYRHPFHMTPMPYDLQGLDFFPFLSGDNQHYNTSLLAAAAAAVSDDQDLLHSSRFFPYTSSQMFLDQLSAGGSTSLPTTNGSSSGSNSSLVSSNSLRESHSHTVTNRSSTDTASIFGIIPDIISLD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

